V
Vitals.com
Take control of your health care needs. Vitals gives you the tools to find the right doctor at the right time
About Vitals.com
Vitals.com is a Dutch company that specializes in the development and distribution of high-quality nutritional supplements. The company focuses on providing a wide range of products, including vitamins, minerals, and specialty supplements like Nattokinase-NSK, an enzyme derived from fermented soybeans. Vitals.com emphasizes the scientific basis of its products, ensuring optimal dosage, absorbability, and efficacy of the ingredients. The product line also includes organic-certified supplements, with approximately 15 products meeting the Skal Bio Controle (NL-BIO-01) standards. The company's offerings cater to various health needs, including cardiovascular health with products like the 'Hart en Vaatformule Pro,' and general wellness with items such as 'Ultimate Fibre Blend' and 'Calcium Biologisch.' Vitals.com's business model is centered on direct-to-consumer sales through its website, vitals.nl, and likely through partnerships with health practitioners and retailers. The company targets health-conscious individuals, athletes, and those seeking to supplement their diet for specific health goals, such as active aging or enhanced physical performance. The market for Vitals.com is primarily in the Netherlands and potentially other European countries, operating within the competitive nutritional supplement industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- Lyndhurst, United States
- Employees
- 62
- Open positions
- None listed
- Dealroom signal
- 72.0/100
- Industry
- Health, Telecom
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Oncology, Neurology
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Dec 2015 | $41M | $164M | Goldman Sachs | — |
| LATE VCOther financing | Jun 2013 | $22M | $88M | Health Enterprise Partners · Milestone Venture Group · Greycroft Partners · Cardinal Partners | — |
Growth signals
Latest recorded traffic for Vitals.com is 1M monthly website visits, down 9.1% over the last three months. Vitals.com's team declined 6.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later4 investors entered at this stage
Health Enterprise Partners
Milestone Venture Group
Cardinal Partners
Goldman Sachs
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vitals.com on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vitals.com’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.